Stay updated on Benralizumab in HES: Efficacy and Safety Clinical Trial
Sign up to get notified when there's something new on the Benralizumab in HES: Efficacy and Safety Clinical Trial page.

Latest updates to the Benralizumab in HES: Efficacy and Safety Clinical Trial page
- Check5 days agoChange DetectedA notice about NIH’s terminology transition appears above the site navigation, and the footer revision changes from v3.7.1 to v3.7.2. The study area continues to display a 403 error.SummaryDifference1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe footer’s ClinicalTrials.gov release identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check33 days agoChange DetectedThe page now shows a 403 Forbidden error with minimal navigation, replacing the previously visible study-record content. The detailed study information appears removed or inaccessible, indicating a site access issue rather than a content update.SummaryDifference19%

- Check40 days agoChange DetectedRevision: v3.7.0 has been added and Revision: v3.6.6 has been removed. This reflects an update to the version of the study documentation referenced on the page.SummaryDifference0.0%

- Check54 days agoChange DetectedA new page revision label 'Revision: v3.6.6' was added and the previous label 'Revision: v3.6.5' was removed, indicating a minor update to the page's versioning or documentation metadata.SummaryDifference0.0%

- Check61 days agoChange DetectedTwo NIH grant/contract identifiers for 2019 and 2023 were added to the study record, indicating additional funding acknowledgments associated with the trial.SummaryDifference0.1%

Stay in the know with updates to Benralizumab in HES: Efficacy and Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Benralizumab in HES: Efficacy and Safety Clinical Trial page.